Pfizer Inc Stock Market Capitalization

PFE Stock

USD 25.39 0.03 0.12%

Pfizer Inc fundamentals help investors to digest information that contributes to Pfizer's financial success or failures. It also enables traders to predict the movement of Pfizer Stock. The fundamental analysis module provides a way to measure Pfizer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pfizer stock.

		Last Reported	Projected for Next Year
	Market Cap	218.8 B	229.8 B

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pfizer Inc Company Market Capitalization Analysis

Pfizer's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Market Cap

Shares Outstanding

X

Share Price

More About Market Capitalization | All Equity Analysis

Current Pfizer Market Capitalization

145.47 B

Most of Pfizer's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pfizer Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pfizer Market Capitalization Driver Correlations

Understanding the fundamental principles of building solid financial models for Pfizer is extremely important. It helps to project a fair market value of Pfizer Stock properly, considering its historical fundamentals such as Market Capitalization. Since Pfizer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pfizer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pfizer's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Accounts Payable	Short Term Investments	Capital Stock	Common Stock	Long Term Debt	Good Will	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital
Total Assets		0.77	0.82	0.77	0.54	0.98	0.64	0.35	0.87	0.84	0.87	0.3	0.91	0.91	0.88	0.79	-0.61	0.32	0.44	0.48	0.06	0.54	-0.28	0.08	0.21	-0.14	0.45	-0.36
Total Stockholder Equity	0.77		0.37	0.55	0.72	0.68	0.86	0.21	0.55	0.92	0.62	0.59	0.81	0.81	0.48	0.78	-0.43	0.26	0.29	0.27	-0.07	0.34	-0.15	0.09	-0.04	-0.17	0.28	0.01
Net Debt	0.82	0.37		0.79	0.11	0.88	0.15	0.51	0.81	0.58	0.8	-0.19	0.68	0.68	0.96	0.68	-0.7	0.23	0.46	0.62	0.42	0.68	-0.47	0.06	0.55	-0.13	0.62	-0.7
Retained Earnings	0.77	0.55	0.79		0.13	0.76	0.28	0.28	0.54	0.63	0.92	0.01	0.78	0.78	0.8	0.73	-0.95	0.15	0.68	0.64	0.21	0.93	-0.68	0.24	0.32	-0.54	0.46	-0.41
Net Receivables	0.54	0.72	0.11	0.13		0.46	0.73	0.05	0.41	0.72	0.35	0.42	0.52	0.52	0.25	0.46	0.01	0.39	0.04	0.27	-0.23	-0.08	-0.01	-0.05	-0.14	-0.04	-0.04	0.16
Total Liab	0.98	0.68	0.88	0.76	0.46		0.55	0.46	0.89	0.8	0.84	0.2	0.9	0.9	0.91	0.81	-0.64	0.38	0.38	0.5	0.1	0.56	-0.25	0.05	0.33	-0.08	0.45	-0.42
Total Current Assets	0.64	0.86	0.15	0.28	0.73	0.55		0.03	0.38	0.71	0.38	0.85	0.7	0.7	0.29	0.53	-0.17	0.3	0.09	0.0	-0.35	0.04	0.11	0.03	-0.28	0.02	-0.03	0.33
Short Term Debt	0.35	0.21	0.51	0.28	0.05	0.46	0.03		0.43	0.37	0.2	-0.21	0.43	0.43	0.32	0.65	-0.37	0.48	-0.39	0.18	0.04	0.25	0.03	-0.18	0.86	-0.09	0.18	-0.45
Intangible Assets	0.87	0.55	0.81	0.54	0.41	0.89	0.38	0.43		0.67	0.73	0.05	0.68	0.68	0.82	0.64	-0.36	0.24	0.24	0.45	0.18	0.32	-0.11	-0.23	0.35	0.05	0.56	-0.49
Property Plant Equipment	0.84	0.92	0.58	0.63	0.72	0.8	0.71	0.37	0.67		0.72	0.33	0.87	0.87	0.65	0.9	-0.55	0.39	0.31	0.51	0.09	0.47	-0.26	0.04	0.18	-0.16	0.35	-0.15
Accounts Payable	0.87	0.62	0.8	0.92	0.35	0.84	0.38	0.2	0.73	0.72		0.04	0.76	0.76	0.86	0.71	-0.78	0.07	0.69	0.69	0.26	0.8	-0.62	0.07	0.26	-0.41	0.58	-0.38
Short Term Investments	0.3	0.59	-0.19	0.01	0.42	0.2	0.85	-0.21	0.05	0.33	0.04		0.39	0.39	-0.07	0.16	0.06	0.06	-0.06	-0.31	-0.54	-0.17	0.33	0.08	-0.5	0.1	-0.23	0.55
Capital Stock	0.91	0.81	0.68	0.78	0.52	0.9	0.7	0.43	0.68	0.87	0.76	0.39		1.0	0.72	0.9	-0.73	0.57	0.28	0.46	-0.16	0.59	-0.25	0.08	0.24	-0.28	0.15	-0.15
Common Stock	0.91	0.81	0.68	0.78	0.52	0.9	0.7	0.43	0.68	0.87	0.76	0.39	1.0		0.72	0.9	-0.73	0.57	0.28	0.46	-0.16	0.59	-0.25	0.08	0.24	-0.28	0.15	-0.15
Long Term Debt	0.88	0.48	0.96	0.8	0.25	0.91	0.29	0.32	0.82	0.65	0.86	-0.07	0.72	0.72		0.67	-0.67	0.21	0.59	0.61	0.42	0.65	-0.49	0.14	0.35	-0.08	0.61	-0.61
Good Will	0.79	0.78	0.68	0.73	0.46	0.81	0.53	0.65	0.64	0.9	0.71	0.16	0.9	0.9	0.67		-0.73	0.51	0.17	0.54	0.09	0.63	-0.31	-0.03	0.5	-0.27	0.3	-0.24
Treasury Stock	-0.61	-0.43	-0.7	-0.95	0.01	-0.64	-0.17	-0.37	-0.36	-0.55	-0.78	0.06	-0.73	-0.73	-0.67	-0.73		-0.25	-0.54	-0.62	-0.17	-0.97	0.65	-0.24	-0.42	0.56	-0.3	0.32
Current Deferred Revenue	0.32	0.26	0.23	0.15	0.39	0.38	0.3	0.48	0.24	0.39	0.07	0.06	0.57	0.57	0.21	0.51	-0.25		-0.37	0.21	-0.44	0.06	0.08	-0.15	0.31	-0.17	-0.52	0.05
Net Tangible Assets	0.44	0.29	0.46	0.68	0.04	0.38	0.09	-0.39	0.24	0.31	0.69	-0.06	0.28	0.28	0.59	0.17	-0.54	-0.37		0.43	0.49	0.66	-0.66	0.49	-0.24	-0.23	0.58	-0.34
Total Permanent Equity	0.48	0.27	0.62	0.64	0.27	0.5	0.0	0.18	0.45	0.51	0.69	-0.31	0.46	0.46	0.61	0.54	-0.62	0.21	0.43		0.36	0.67	-0.73	-0.16	0.46	-0.51	0.3	-0.32
Long Term Debt Total	0.06	-0.07	0.42	0.21	-0.23	0.1	-0.35	0.04	0.18	0.09	0.26	-0.54	-0.16	-0.16	0.42	0.09	-0.17	-0.44	0.49	0.36		0.33	-0.47	0.14	0.26	0.21	0.77	-0.58
Capital Surpluse	0.54	0.34	0.68	0.93	-0.08	0.56	0.04	0.25	0.32	0.47	0.8	-0.17	0.59	0.59	0.65	0.63	-0.97	0.06	0.66	0.67	0.33		-0.75	0.24	0.39	-0.56	0.42	-0.36
Deferred Long Term Liab	-0.28	-0.15	-0.47	-0.68	-0.01	-0.25	0.11	0.03	-0.11	-0.26	-0.62	0.33	-0.25	-0.25	-0.49	-0.31	0.65	0.08	-0.66	-0.73	-0.47	-0.75		-0.15	-0.26	0.66	-0.35	0.31
Long Term Investments	0.08	0.09	0.06	0.24	-0.05	0.05	0.03	-0.18	-0.23	0.04	0.07	0.08	0.08	0.08	0.14	-0.03	-0.24	-0.15	0.49	-0.16	0.14	0.24	-0.15		-0.25	0.07	0.13	-0.33
Short Long Term Debt	0.21	-0.04	0.55	0.32	-0.14	0.33	-0.28	0.86	0.35	0.18	0.26	-0.5	0.24	0.24	0.35	0.5	-0.42	0.31	-0.24	0.46	0.26	0.39	-0.26	-0.25		-0.28	0.25	-0.56
Cash And Equivalents	-0.14	-0.17	-0.13	-0.54	-0.04	-0.08	0.02	-0.09	0.05	-0.16	-0.41	0.1	-0.28	-0.28	-0.08	-0.27	0.56	-0.17	-0.23	-0.51	0.21	-0.56	0.66	0.07	-0.28		0.11	0.01
Net Invested Capital	0.45	0.28	0.62	0.46	-0.04	0.45	-0.03	0.18	0.56	0.35	0.58	-0.23	0.15	0.15	0.61	0.3	-0.3	-0.52	0.58	0.3	0.77	0.42	-0.35	0.13	0.25	0.11		-0.67
Net Working Capital	-0.36	0.01	-0.7	-0.41	0.16	-0.42	0.33	-0.45	-0.49	-0.15	-0.38	0.55	-0.15	-0.15	-0.61	-0.24	0.32	0.05	-0.34	-0.32	-0.58	-0.36	0.31	-0.33	-0.56	0.01	-0.67

Click cells to compare fundamentals

Pfizer Market Capitalization Historical Pattern

Today, most investors in Pfizer Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pfizer's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Pfizer market capitalization as a starting point in their analysis.

Pfizer Market Capitalization

Timeline

In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Competition

Predict Pfizer

Market Cap Over Time

Pfizer Long Term Debt To Capitalization

Long Term Debt To Capitalization

0.43

At present, Pfizer's Long Term Debt To Capitalization is projected to increase slightly based on the last few years of reporting.

Based on the recorded statements, the market capitalization of Pfizer Inc is about 145.47 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The market capitalization for all United States stocks is significantly lower than that of the firm.

Pfizer Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pfizer's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics of similar companies.

Pfizer is currently under evaluation in market capitalization category among related companies.

Pfizer ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pfizer's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pfizer's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Pfizer Fundamentals

	Return On Equity	0.0235
	Return On Asset	0.0155
	Profit Margin	0.04 %
	Operating Margin	(0.50) %
	Current Valuation	207.98 B
	Shares Outstanding	5.66 B
	Shares Owned By Insiders	0.04 %
	Shares Owned By Institutions	69.93 %
	Number Of Shares Shorted	65 M
	Price To Earning	9.48 X
	Price To Book	1.65 X
	Price To Sales	2.50 X
	Revenue	58.5 B
	Gross Profit	66.23 B
	EBITDA	10.53 B
	Net Income	2.13 B
	Cash And Equivalents	2.85 B
	Cash Per Share	6.44 X
	Total Debt	75.04 B
	Debt To Equity	0.40 %
	Current Ratio	1.59 X
	Book Value Per Share	15.77 X
	Cash Flow From Operations	8.7 B
	Short Ratio	1.40 X
	Earnings Per Share	0.37 X
	Price To Earnings To Growth	0.26 X
	Target Price	31.1
	Number Of Employees	88 K
	Beta	0.57
	Market Capitalization	145.47 B
	Total Asset	226.5 B
	Retained Earnings	118.35 B
	Working Capital	(4.46 B)
	Current Asset	43.8 B
	Current Liabilities	29.4 B
	Annual Yield	0.07 %
	Five Year Return	3.60 %
	Net Asset	226.5 B
	Last Dividend Paid	1.64

About Pfizer Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:

How To Invest In Pfizer

Details

Is Pfizer Stock a good investment?

Details

What is Pfizer's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Pfizer Piotroski F Score and Pfizer Altman Z Score analysis.

Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Commodity Directory Find actively traded commodities issued by global exchanges

Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.76)

Dividend Share

1.64

Earnings Share

0.37

Revenue Per Share

10.366

Quarterly Revenue Growth

(0.41)

The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pfizer Inc Stock Market Capitalization

Pfizer Inc Company Market Capitalization Analysis

Market Cap

Shares Outstanding

X

Share Price

Current Pfizer Market Capitalization

Pfizer Market Capitalization Driver Correlations

Pfizer Market Capitalization Historical Pattern

Pfizer Long Term Debt To Capitalization

Long Term Debt To Capitalization

0.43

Pfizer Market Capitalization Peer Comparison

Pfizer ESG Sustainability

Pfizer Fundamentals

About Pfizer Fundamental Analysis

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Pfizer Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY